Browsing by Author "Mugerwa, Henry"
-
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial
Paton, Nichilas I.; Musaazi, Joseph; Kityo, Cissy; Walimbwa, Stephen; Hoppe, Anne; Balyegisawa, Apolo; Asienzo, Jesca; Kaimal, Arvind; Mirembe, Grace; Lugemwa, Abbas; Ategeka, Gilbert; Borok, Margaret; Mugerwa, Henry; Siika, Abraham; Odongpiny, Eva Laker A.; Castelnuovo, Barbara; Kiragga, Agnes; Kambugu, Andrew (Elsevier, 2022-04-20)Background WHO guidelines recommend dolutegravir plus two nucleoside reverse transcriptase inhibitors (NRTIs) for second-line HIV therapy, with NRTI switching from first-line tenofovir to zidovudine. We aimed to ... -
High Prevalence of tuberculosis infection among medical students in Makerere University, Kampala: Results of a cross sectional study.
Mugerwa, Henry; Byarugaba, Denis K.; Mpooya, Simon; Miremba, Penelope; Kalyango, Joan N; Karamagi, Charles; Katamba, Achilles (BioMed Central, 2013)Background: Uganda’s Ministry of Health registered a 12% increase in new Tuberculosis (TB) cases between 2001 and 2005. Of these, 20% were from Kampala district and most from Mulago national referral hospital where ... -
Prevalence and associated factors of tuberculosis infection among medical and veterinary undergraduate students in Makerere University, Kampala, Uganda
Mugerwa, Henry (Makerere University, 2011-04)Introduction: Uganda ranks 16th on the list of 22 high-burden tuberculosis (TB) countries in the world. Medical students are likely to have an increased exposure to TB infection due to their training in hospitals compared ...